Click here to view original web page at beckernews.com
Promoted Content The Omicron variant, the latest Covid mutation grabbing international headlines, is already causing a devastating ripple effect throughout the world. Global authorities in the U.K. and the E.U. are tightening their borders in anticipation of another Covid wave.
In the United States, New York’s governor Kathy Hochul has already canceled elective surgeries in the state citing the Omicron variant, even as the transmissibility and deadliness of this latest Covid mutation are unknown. The variant is believed to have originated in Botswana, and may be playing a role in a Covid surge in South Africa. The variant has been identified in Botswana, South Africa, Hong Kong, and Amsterdam in The Netherlands.
Pfizer-BioNTech, fresh off sky-high profits off of its government-mandated ‘vaccines,’ is already mullying a ‘ future relaunch ‘ of a Covid-19 vaccine to deal with the Omicron variant. It looks like a lesser-known pharmaceutical company, Novavax, however, may beat it to the punch.
Novavax said on Friday it has “started working on a version of its COVID-19 vaccine to target the variant detected in South Africa” and “would have the shot ready for testing and manufacturing in the next few weeks,” Reuters reported .
“The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system,” Reuters noted. “The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.”
“The initial work will take a few weeks,” a company spokesperson said. “Shares of the company closed up nearly 9% on Friday.”
The report notes that Novavax’s vaccine received its first emergency use approval earlier this month in Indonesia, followed by the Philippines.
Christian-Driven America-First Precious Metals.
Before markets collapse, the smart play is to move wealth or retirement to precious metals. Contact Genesis Gold now to make it happen smoothly with no hassles from a group driven by fellowship.
“The company has said it is on track to file for U.S. approval by the end of the year,” the report continued. “It has also filed for approvals with the European Medicines Agency as well as in Canada.”
Novavax’s statement indicates a potential continuation of the track record of Covid vaccines that are patented and developed ‘too quickly.’ Before SARS-CoV-2 burst onto the global scene in December 2019, it was expected […]
Click here to view original web page at beckernews.com
We Often Feel Like David Taking on Giants
Today’s Goliath is the Mainstream Media Industrial Complex that brainwashes the masses.
Our mission is very straightforward: To counter the false narratives and nefarious agendas destroying America today. It isn’t easy for obvious reasons; despite incredible growth over the last year we are still a very tiny fish in a huge media pond. But we’re fighting and we will continue to do so, Lord willing, for as long as we possibly can. The battle for America’s present and future is too important for us to back down to the giants that stand in our way.
We need help. I don’t want to say “desperately,” but the need is definitely great. If you have the means, please donate through our GivingFuel page, PayPal, or our Substack page. Your generosity is what keeps these sites running and allows us to get the truth to the masses. We’ve had great success in growing but we know we can do more with your assistance.
Thank you, and God Bless!
JD Rucker